PINK COPYRIGHT: A GROWING DANGER?

A concerning trend is surfacing within the drug scene: "Pink copyright," formally known as Flunitramadol. This manufactured opioid is being marketed as a crystal , often packaged as copyright, posing a significant risk to individuals . Its relatively low expense and easy accessibility are fueling